Press Release – New York, NY – February 27, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented Basel Medical Group Ltd, a Singapore-based clinical provider of general and subspecialized orthopedic and trauma services, sports medicine and surgery, orthopedic procedures, as well as neurosurgical treatments, in an $8,820,000 initial public offering of ordinary shares (NASDAQ: BMGL). The initial public offering consisted of 2,205,000 ordinary shares issued and sold by Basel Medical Group Ltd at a public offering price of $4.00 per share.
Cathay Securities, Inc. acted as the lead underwriter and Revere Securities LLC acted as co-underwriter for this offering
The Sichenzia Ross Ference Carmel LLP team was led by partner Benjamin Tan and counsel, Martryn Mak.
